Please leave a message
Official opening of bm research center in taizhou

News

Official opening of bm research center in taizhou

2024-08-13

The forensic identification kit project implemented by BM Taizhou in Taizhou Medical City at the end of 2023 is an important manifestation of our company's R&D strength and innovation ability. This project not only marks BM's profound development in forensic science and technology, but also heralds new breakthroughs in forensic identification technology in the future.

 

news13

 

As a key scientific tool in court, forensic identification kits are playing an increasingly important role in the investigation and detection of crimes and criminal proceedings. As the report notes, DNA evidence is known as the "king of evidence" and plays a crucial role in identifying suspects in crimes, identifying abducted children and characterizing drug cases. BM Taizhou's forensic identification kit project responds to this need and aims to develop more sensitive and accurate forensic identification tools. The main objective of the project is to increase the sensitivity and stability of the kits, especially in complex cases of contact samples, inhibition and degradation.

 

news14

 

In addition, the policy of supporting the pharmaceutical industry in Taizhou City creates favorable conditions for the development of forensic reagent production projects of Shenzhen BM and other companies. The implementation of this policy not only strengthens our sense of identity and accessibility, but also has a good agglomeration effect and contributes to the high-quality development of the pharmaceutical industry. With the continuous advancement of the project and the gradual transformation of the research and development results, the Shenzhen BM forensic identification kit is set to become a bright calling card in the field of forensic medicine and technology in Taizhou City and even in China.

 

news15

 

The upcoming project to produce fillers for solid-phase extraction (TPE) and silica gel membranes at BM's Dongguan plant marks a significant step forward in cost control for BM's life sciences business. This initiative will not only improve production efficiency and ensure product quality, but also significantly reduce production costs through vertical integration of the supply chain. As an indispensable material in chemical analysis and biomedical research, the expansion of the independent production of fillers for solid-phase extraction will provide a solid material foundation for BM's continuous innovation and research in the field of life sciences. At the same time, the production of silica gel membrane will contribute to the further improvement of the company's product line and increase its competitiveness in the market. Through the implementation of these projects, BM will be able to respond more flexibly to market changes and offer customers more cost-effective solutions, thereby gaining a better competitive position in the life sciences industry.